UNSPSC 51151665: Zamifenacin

This classification denotes an antimuscarinic agent with the molecular formula C27H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y88Q418Y7M, chemically known as piperidine, 1-(2-(1,3-benzodioxol-5-yl)ethyl)-3-(diphenylmethoxy)-, (+-)- but generally known as zamifenacin, which bears US NIH Compound Identifier 124431. European Medicines Agency schedules Zamifenacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00136MIG.

UNSPSC 51151665 Zamifenacin, a Commodity code, sees minimal recent state and local procurement activity tied directly to its nominal scope. The single recent opportunity on record—Seminole County, Florida's IFB for Naloxone and Drug Deactivation Systems (IFB60459723LAS, posted June 30, 2026, response deadline July 26, 2023)—involves naloxone, an opioid antagonist used in overdose response, rather than zamifenacin, an antimuscarinic agent used in urological treatment. The mismatch suggests either a coding error in the opportunity posting or minimal alignment between the code's pharmaceutical definition and what state and local jurisdictions are actually buying under this UNSPSC classification. State and local bodies do procure emergency medical supplies and pharmaceuticals, but this code shows little relevant recent activity.

Seminole County's solicitation represents public health infrastructure spending: the county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors were required to provide all shipping and delivery costs, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation and commercial general liability insurance. The contract carried a two-year initial term with a one-year renewal option and included a three-month probationary period. Without additional recent opportunities under this code from other state or local jurisdictions, the geographic and issuing-body patterns remain unclear. The code warrants close attention to future solicitations to determine whether recent activity reflects genuine procurement demand or a classification anomaly.